866 related articles for article (PubMed ID: 32873233)
21. [Evaluation of the effectiveness of BMRT-HPV for cervical cancer screening].
Duan LF; Du H; Wang C; Huang X; Qu XF; Duan XZ; Liu Y; Shi B; Zhang W; Wei LH; Belinson L; Wu RF
Zhonghua Fu Chan Ke Za Zhi; 2020 Oct; 55(10):708-715. PubMed ID: 33120484
[No Abstract] [Full Text] [Related]
22. Detection of cervical high-grade squamous intraepithelial lesions and assessing diagnostic performance of colposcopy among women with oncogenic HPV.
Li X; Xiang F; Zhao Y; Li Q; Gu Q; Zhang X; Chen Z; Zhang M; Wang J; Liu R; Kang X; Wu R
BMC Womens Health; 2023 Aug; 23(1):411. PubMed ID: 37542333
[TBL] [Abstract][Full Text] [Related]
23. Incidence of cervical high-grade squamous intraepithelial lesions and squamous cell carcinoma in women with high-risk human papillomavirus and normal cervical cytology: A retrospective analysis of 1858 cases stratified by age and human papillomavirus genotype.
Gu L; Hong Z; Gao H; Qiu L; Di W
Cytopathology; 2019 Jul; 30(4):419-425. PubMed ID: 31069857
[TBL] [Abstract][Full Text] [Related]
24. Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence.
Kjær SK; Frederiksen K; Munk C; Iftner T
J Natl Cancer Inst; 2010 Oct; 102(19):1478-88. PubMed ID: 20841605
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of HPV-16 and HPV-18 genotyping for the triage of women with high-risk HPV+ cytology-negative results.
Wright TC; Stoler MH; Sharma A; Zhang G; Behrens C; Wright TL;
Am J Clin Pathol; 2011 Oct; 136(4):578-86. PubMed ID: 21917680
[TBL] [Abstract][Full Text] [Related]
26. [Real-world research on cervical cancer screening program and effect evaluation for Chinese population].
Zhao YQ; Dai Y; Dang L; Kong LH; Zhang Y; Feng RM; Qiao YL; Lang JH
Zhonghua Zhong Liu Za Zhi; 2018 Oct; 40(10):764-771. PubMed ID: 30392341
[No Abstract] [Full Text] [Related]
27. A Low-Cost HPV Immunochromatographic Assay to Detect High-Grade Cervical Intraepithelial Neoplasia.
Mariano VS; Lorenzi AT; Scapulatempo-Neto C; Stein MD; Resende JC; Antoniazzi M; Villa LL; Levi JE; Longatto-Filho A; Fregnani JH
PLoS One; 2016; 11(10):e0164892. PubMed ID: 27764154
[TBL] [Abstract][Full Text] [Related]
28. 16/18 genotyping in triage of persistent human papillomavirus infections with negative cytology in the English cervical screening pilot.
Rebolj M; Brentnall AR; Mathews C; Denton K; Holbrook M; Levine T; Sargent A; Smith J; Tidy J; Tyler X; Kitchener H;
Br J Cancer; 2019 Sep; 121(6):455-463. PubMed ID: 31409912
[TBL] [Abstract][Full Text] [Related]
29. Management of HPV-positive women in cervical screening using results from two consecutive screening rounds.
Polman NJ; Veldhuijzen NJ; Heideman DAM; Snijders PJF; Meijer CJLM; Berkhof J
Int J Cancer; 2019 May; 144(9):2339-2346. PubMed ID: 30565673
[TBL] [Abstract][Full Text] [Related]
30. Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting.
Leinonen M; Nieminen P; Kotaniemi-Talonen L; Malila N; Tarkkanen J; Laurila P; Anttila A
J Natl Cancer Inst; 2009 Dec; 101(23):1612-23. PubMed ID: 19903804
[TBL] [Abstract][Full Text] [Related]
31. Risks for cervical abnormalities in women with non-16/18 high-risk human papillomavirus infections in south Shanghai, China.
Wang X; Wu S; Li Y
J Med Virol; 2021 Nov; 93(11):6355-6361. PubMed ID: 34232523
[TBL] [Abstract][Full Text] [Related]
32. Human papillomavirus test with cytology triage in organized screening for cervical cancer.
Veijalainen O; Kares S; Kujala P; Tirkkonen M; Vuento R; Kholová I; Luukkaala T; Osuala V; Mäenpää J
Acta Obstet Gynecol Scand; 2016 Nov; 95(11):1220-1227. PubMed ID: 27591407
[TBL] [Abstract][Full Text] [Related]
33. Assessing the time dependence of prognostic values of cytology and human papillomavirus testing in cervical cancer screening.
Isidean SD; Wang Y; Mayrand MH; Ratnam S; Coutlée F; Franco EL; Abrahamowicz M;
Int J Cancer; 2019 May; 144(10):2408-2418. PubMed ID: 30411802
[TBL] [Abstract][Full Text] [Related]
34. Primary screening for cervical cancer based on high-risk human papillomavirus (HPV) detection and HPV 16 and HPV 18 genotyping, in comparison to cytology.
Agorastos T; Chatzistamatiou K; Katsamagkas T; Koliopoulos G; Daponte A; Constantinidis T; Constantinidis TC;
PLoS One; 2015; 10(3):e0119755. PubMed ID: 25793281
[TBL] [Abstract][Full Text] [Related]
35. Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial.
Canfell K; Caruana M; Gebski V; Darlington-Brown J; Heley S; Brotherton J; Gertig D; Jennett CJ; Farnsworth A; Tan J; Wrede CD; Castle PE; Saville M
PLoS Med; 2017 Sep; 14(9):e1002388. PubMed ID: 28926579
[TBL] [Abstract][Full Text] [Related]
36. Prevalence and genotyping of high risk human papillomavirus in cervical cancer samples from Punjab, Pakistan.
Siddiqa A; Zainab M; Qadri I; Bhatti MF; Parish JL
Viruses; 2014 Jul; 6(7):2762-77. PubMed ID: 25036463
[TBL] [Abstract][Full Text] [Related]
37. Effect of Sequential Rounds of Cervical Cancer Screening on Management of HPV-positive Women: A 15-year Population-based Cohort Study from China.
Xu XQ; Rezhake R; Hu SY; Chen F; Zhang X; Pan QJ; Zhang WH; Ma JF; Qiao YL; Zhao FH; Cruickshank M
Cancer Prev Res (Phila); 2021 Mar; 14(3):363-372. PubMed ID: 33303694
[TBL] [Abstract][Full Text] [Related]
38. Predominance of high-risk human papillomavirus genotype 16 and 39 in women with premalignant and malignant cervical pathology from Raipur, Chhattisgarh: Clinical evaluation of tagging oligonucleotide cleavage and extension mediated genotyping assay.
Negi SS; Bhargava A; Singh P; Aggarwal S; Hussain N; Das P
Indian J Med Microbiol; 2019; 37(2):255-262. PubMed ID: 31745028
[TBL] [Abstract][Full Text] [Related]
39. [Clinical value of human papillomavirus genotyping testing in the diagnosis of cervical intraepithelial neoplasia].
Liu G; Yu L; Song H; Mi R; Chen Y
Zhonghua Fu Chan Ke Za Zhi; 2014 Jun; 49(6):446-50. PubMed ID: 25169638
[TBL] [Abstract][Full Text] [Related]
40. Clinical validation of the Cervista HPV HR and 16/18 genotyping tests for use in women with ASC-US cytology.
Einstein MH; Martens MG; Garcia FA; Ferris DG; Mitchell AL; Day SP; Olson MC
Gynecol Oncol; 2010 Aug; 118(2):116-22. PubMed ID: 20488510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
